1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Conference Papers Year : 2023

1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans

Abstract

Using total tumor volume and AI tumor heterogeneity from CT scans, it may be possible to predict the prognosis of oncology patients, identify those who could benefit from immunotherapy, and provide valuable guidance for treatment.

Dates and versions

hal-04396366 , version 1 (15-01-2024)

Identifiers

Cite

Lama Dawi, Samy Ammari, Younes Belkouchi, Joya Hadchiti, L. Lawrance, et al.. 1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans. ESMO 2023 - Congress of European Society for Medical Oncology, European Society for Medical Oncology, Oct 2023, Madrid, Spain. pp.S622, ⟨10.1016/j.annonc.2023.09.2161⟩. ⟨hal-04396366⟩
42 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More